Records containing: Leishmaniasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20Host Response to Infection and Treatment in Leishmania Infection of Humans
-
CLINICAL_TRIALS study record update · 2026-01-22Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
-
CLINICAL_TRIALS study record update · 2025-04-24A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan
-
CLINICAL_TRIALS study record update · 2025-03-20Mediterranean Visceral Leishmaniasis With Leishmania Infantum: Genetic Characterization of the Host Parasite in Relation to Asymptomatic Human Carriage
-
CLINICAL_TRIALS study record update · 2025-03-05Seroprevalence of Zoonotic and Arboviral Emerging Infections in Exposed Agents from the City of Montpellier: a Transversal Study.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-12Safety and Pharmacokinetics of Oleylphosphocholine (OlPC), Administered Orally in Healthy Adults: A Phase 1, Single Center, Open-label, Staggered, Dose-escalation Trial
-
CLINICAL_TRIALS study record update · 2024-03-12Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
-
CLINICAL_TRIALS study record update · 2024-02-22A Randomized, Double-blind, Placebo-controlled, First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single (in Both Fed and Fasted States) Doses of GSK3494245 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2024-01-16The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: An Open-label, Randomized Clinical Trial in Brazil
-
CLINICAL_TRIALS study record update · 2023-11-09A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies
-
CLINICAL_TRIALS study record update · 2023-02-27A Randomized, Double-blind (Sponsor Unblinded), Placebo-controlled, First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single (in Both Fed and Fasted States) and Repeat Doses of GSK3186899 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2022-03-15Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
-
CLINICAL_TRIALS study record update · 2021-12-08Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
-
CLINICAL_TRIALS study record update · 2021-02-02Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
-
CLINICAL_TRIALS study record update · 2020-08-28Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
-
CLINICAL_TRIALS study record update · 2020-03-30Intervenable Host- Leishmania (Vianna) Interactions Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection Aim 1: To Determine if Th1/Th2 Polarization Occurs and is Linked to the Outcome of Infection by L. Viannia
-
CLINICAL_TRIALS study record update · 2020-03-30Immune and Inflammatory Responses in L. (Viannia) Infection Aim 2: Expression of Mif Alleles in Individuals With Recurrent Leishmaniasis, Chronic Leishmaniasis and Asymptomatic Infection
-
CLINICAL_TRIALS study record update · 2020-03-30Intervenable Host - Leishmania (Viannia) Interactions - Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection - Aim 3: Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection
-
CLINICAL_TRIALS study record update · 2020-03-19AIDS Defining Opportunistic Infections in Naive HIV Cases
-
CLINICAL_TRIALS study record update · 2018-02-27Department of Defense Protocol for the Use of Sodium Stibogluconate (Pentostam) as a Treatment for Leishmaniasis
-
CLINICAL_TRIALS study record update · 2017-09-26Transition-state Analog Inhibitor of Human Purine Nucleoside Phosphorylase as an Adjunct in Cutaneous Leishmaniasis Therapy: a Randomized and Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-03-09Sodium Stibogluconate Treatment of Leishmaniasis
-
CLINICAL_TRIALS study record update · 2017-01-04ClinicalTrials.gov study NCT03009422
-
CLINICAL_TRIALS study record update · 2017-01-02A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of the Vaccine Candidates LEISH-F3 + GLA-SE, LEISH-F3 + MPL-SE, and LEISH-F3 + SE in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2015-06-09Randomized Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis at Federal District, Brazil